Display options
Cite
Yu SN, Ma YH, Zhao WG, et al. . Chronic Dis Transl Med. 2016;2(4):215-222doi: 10.1016/j.cdtm.2016.11.012.
Yu, S. N., Ma, Y. H., Zhao, W. G., Jin, X. L., Yang, H. Y., Liu, P. P., & Chen, J. (2016). . Chronic diseases and translational medicine, 2(4), 215-222. https://doi.org/10.1016/j.cdtm.2016.11.012
Yu, Shuang-Ni, et al. "." Chronic diseases and translational medicine vol. 2,4 (2016): 215-222. doi: https://doi.org/10.1016/j.cdtm.2016.11.012
Yu SN, Ma YH, Zhao WG, Jin XL, Yang HY, Liu PP, Chen J. . Chronic Dis Transl Med. 2016 Dec 22;2(4):215-222. doi: 10.1016/j.cdtm.2016.11.012. eCollection 2016 Dec. PMID: 29063045; PMCID: PMC5643763.
Copy Download .nbib Format: NLM
Share it on

Chronic Dis Transl Med. 2016 Dec 22;2(4):215-222. doi: 10.1016/j.cdtm.2016.11.012. eCollection 2016 Dec.

[No title available]

Chronic diseases and translational medicine

Shuang-Ni Yu, Yi-Hui Ma, Wu-Gan Zhao, Xiang-Lan Jin, Hai-Yan Yang, Ping-Ping Liu, Jie Chen

Affiliations

  1. Department of Pathology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Tsinghua University, Beijing 100730, China.
  2. Department of Pathology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan 450052, China.
  3. Department of Pathology, Peking University Shenzhen Hospital, Shenzhen, Guangdong 518036, China.
  4. Department of Pathology, The Second Hospital of Hebei Medical University, Shijiazhuang, Hebei 050000, China.
  5. Department of Pathology, China-Japan Friendship Hospital, Beijing 100029, China.

PMID: 29063045 PMCID: PMC5643763 DOI: 10.1016/j.cdtm.2016.11.012

Abstract

Pancreatic ductal adenocarcinoma (PDAC) is a lethal disease with a poor overall prognosis. However, curative resection during the early stages of the disease can greatly improve survival rates, highlighting the importance of early screening and detection. Studies of noncoding RNAs, primarily microRNAs (miRNAs) and long noncoding RNAs (lncRNAs), provide important insights into strategies for the early detection of

Keywords: KRAS; Long noncoding RNAs; Noncoding RNAs; Pancreatic ductal adenocarcinoma; microRNAs

References

  1. Cancer Med. 2016 Apr;5(4):693-702 - PubMed
  2. Int J Oncol. 1993 May;2(5):753-8 - PubMed
  3. Cell. 2005 Mar 11;120(5):635-47 - PubMed
  4. Clin Chem. 2010 Apr;56(4):603-12 - PubMed
  5. Cell Cycle. 2012 Jan 15;11(2):361-6 - PubMed
  6. BMC Cancer. 2012 Mar 22;12:105 - PubMed
  7. PLoS Biol. 2007 Sep 4;5(10):e254 - PubMed
  8. Epigenomics. 2015;7(3):333-5 - PubMed
  9. Clin Cancer Res. 2012 Aug 15;18(16):4303-12 - PubMed
  10. Microrna. 2012;1(1):65-9 - PubMed
  11. Carcinogenesis. 2010 Oct;31(10 ):1726-33 - PubMed
  12. PLoS One. 2012;7(2):e32068 - PubMed
  13. Curr Drug Targets. 2013 Sep;14(10):1175-84 - PubMed
  14. Int J Mol Sci. 2015 Mar 24;16(4):6677-93 - PubMed
  15. Int J Cancer. 2009 Oct 15;125(8):1965-74 - PubMed
  16. J Clin Oncol. 2009 Dec 1;27(34):5848-56 - PubMed
  17. Langenbecks Arch Surg. 1998 Apr;383(2):129-33 - PubMed
  18. J Biol Chem. 2009 Aug 28;284(35):23204-16 - PubMed
  19. Cancer J. 2012 May-Jun;18(3):238-43 - PubMed
  20. Cancer Lett. 2009 Jan 18;273(2):233-42 - PubMed
  21. Drug Dev Res. 2015 Sep;76(6):328-42 - PubMed
  22. Diagn Pathol. 2016 Jun 07;11(1):47 - PubMed
  23. CA Cancer J Clin. 2016 Mar-Apr;66(2):115-32 - PubMed
  24. Curr Opin Genet Dev. 2006 Apr;16(2):203-8 - PubMed
  25. Cell. 1993 Dec 3;75(5):843-54 - PubMed
  26. Am J Cancer Res. 2015 Feb 15;5(3):1251-64 - PubMed
  27. Oncogene. 2011 Jan 20;30(3):275-86 - PubMed
  28. Cancer Res. 2004 Aug 15;64(16):5556-9 - PubMed
  29. Science. 2008 Sep 26;321(5897):1801-6 - PubMed
  30. Genes Dev. 2010 Dec 15;24(24):2754-9 - PubMed
  31. Oncogene. 2015 Sep 10;34(37):4867-78 - PubMed
  32. Semin Oncol. 2015 Feb;42(1):28-39 - PubMed
  33. J Cell Biochem. 2013 Jun;114(6):1374-84 - PubMed
  34. Oncogene. 2011 May 26;30(21):2433-42 - PubMed
  35. Genes Dev. 2007 Mar 15;21(6):694-707 - PubMed
  36. Cell Oncol (Dordr). 2016 Aug;39(4):295-318 - PubMed
  37. Oncogene. 2016 Jul 14;35(28):3647-57 - PubMed
  38. Cancer Res. 2007 Nov 15;67(22):11001-11 - PubMed
  39. Mol Cancer Ther. 2009 May;8(5):1067-74 - PubMed
  40. Cancer Res. 2008 Oct 15;68(20):8535-40 - PubMed
  41. Drug Discov Today. 2016 Dec;21(12 ):1915-1919 - PubMed
  42. N Engl J Med. 2014 Sep 11;371(11):1039-49 - PubMed
  43. Pathol Oncol Res. 2015 Sep;21(4):1259-64 - PubMed
  44. Cancer J. 2012 Nov-Dec;18(6):492-501 - PubMed
  45. Cancer Lett. 2012 Jun 28;319(2):173-181 - PubMed
  46. Dev Biol. 2007 Feb 1;302(1):1-12 - PubMed
  47. Int J Oncol. 2014 Oct;45(4):1391-400 - PubMed
  48. Nat Genet. 2005 Jul;37(7):766-70 - PubMed
  49. Bioinformatics. 2013 Oct 15;29(20):2617-24 - PubMed
  50. J Cancer. 2016 May 20;7(8):991-1001 - PubMed
  51. Cancer Res. 2010 Jul 15;70(14 ):6015-25 - PubMed
  52. Carcinogenesis. 2009 Jun;30(6):1003-7 - PubMed
  53. Nat Rev Genet. 2011 Oct 12;12(11):742 - PubMed
  54. Mol Cancer. 2011 Nov 13;10:141 - PubMed
  55. Tumour Biol. 2014 Sep;35(9):9163-9 - PubMed
  56. Oncogene. 2013 Mar 28;32(13):1616-25 - PubMed
  57. Funct Integr Genomics. 2017 May;17 (2-3):203-212 - PubMed
  58. Mol Cancer Ther. 2016 Sep;15(9):2232-43 - PubMed
  59. CA Cancer J Clin. 2016 Jan-Feb;66(1):7-30 - PubMed
  60. Ann Oncol. 2011 Jan;22(1):104-9 - PubMed
  61. Nat Med. 2004 Aug;10 (8):789-99 - PubMed
  62. PLoS One. 2015 Apr 23;10(4):e0125515 - PubMed
  63. Biochem Soc Trans. 2012 Aug;40(4):902-6 - PubMed
  64. Cell. 1988 May 20;53(4):549-54 - PubMed
  65. Hum Gene Ther. 2009 Aug;20(8):831-44 - PubMed
  66. Cancer Lett. 2010 Dec 8;298(2):150-8 - PubMed
  67. Cell Physiol Biochem. 2015 ;35(1):184-90 - PubMed
  68. Chir Ital. 2000 May-Jun;52(3):263-70 - PubMed

Publication Types